0001127602-18-034303.txt : 20181126 0001127602-18-034303.hdr.sgml : 20181126 20181126162238 ACCESSION NUMBER: 0001127602-18-034303 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181121 FILED AS OF DATE: 20181126 DATE AS OF CHANGE: 20181126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Lynne CENTRAL INDEX KEY: 0001631667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 181201095 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-11-21 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001631667 Powell Lynne 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - CCO Common Stock 2018-11-21 4 M 0 12000 3.22 A 14455 D Common Stock 2018-11-21 4 S 0 12000 9.06 D 2455 D Common Stock 2018-11-21 4 S 0 2455 9.01 D 0 D Emp. Stock Option (Right to Buy) 3.22 2018-11-21 4 M 0 12000 0 D 2017-05-23 2026-05-23 Common Stock 12000 101427 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.80 to $9.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Alane P. Barnes, by power of attorney 2018-11-26